Desmosterol in human nonalcoholic steatohepatitis (Q43589156)

25 November 2017

Desmosterol in human nonalcoholic steatohepatitis (English)

1 reference

25 November 2017

0 references

Dorota Kaminska

4

0 references

Jussi Pihlajamäki

object named as

Jussi Pihlajamäki

11

0 references

Markku Laakso

10

object named as

Markku Laakso

1 reference

25 November 2017

8

Johanna Kuusisto

1 reference

25 November 2017

9

Helena Gylling

1 reference

25 November 2017

5

Vesa Kärjä

1 reference

25 November 2017

7

Pirjo Käkelä

1 reference

25 November 2017

6

Sari Venesmaa

1 reference

25 November 2017

Marko Simonen

1

1 reference

25 November 2017

Ville Männistö

2

1 reference

25 November 2017

Joel Leppänen

3

1 reference

25 November 2017

language of work or name

English

0 references

publication date

29 July 2013

1 reference

25 November 2017

1 reference

25 November 2017

58

1 reference

25 November 2017

3

1 reference

25 November 2017

976-982

1 reference

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

25 November 2017

1 reference

Liver fat in the metabolic syndrome.

21 January 2018

1 reference

Non-alcoholic fatty liver disease from pathogenesis to management: an update

21 January 2018

1 reference

Overproduction of large VLDL particles is driven by increased liver fat content in man.

21 January 2018

1 reference

Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects

21 January 2018

1 reference

The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

21 January 2018

1 reference

Long-term follow-up of patients with NAFLD and elevated liver enzymes

21 January 2018

1 reference

Decreased survival of subjects with elevated liver function tests during a 28-year follow-up.

21 January 2018

1 reference

Common variants at 30 loci contribute to polygenic dyslipidemia

21 January 2018

1 reference

Effects of 34 risk loci for type 2 diabetes or hyperglycemia on lipoprotein subclasses and their composition in 6,580 nondiabetic Finnish men.

21 January 2018

1 reference

Body weight modulates cholesterol metabolism in non-insulin dependent type 2 diabetics

21 January 2018

1 reference

Insulin resistance is associated with increased cholesterol synthesis and decreased cholesterol absorption in normoglycemic men.

21 January 2018

1 reference

Insulin sensitivity regulates cholesterol metabolism to a greater extent than obesity: lessons from the METSIM Study

21 January 2018

1 reference

Lipids and lipoproteins as risk factors for coronary heart disease in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

Triglyceride accumulation protects against fatty acid-induced lipotoxicity

21 January 2018

1 reference

Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.

21 January 2018

1 reference

A lipidomic analysis of nonalcoholic fatty liver disease.

21 January 2018

1 reference

Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH.

21 January 2018

1 reference

Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitis

21 January 2018

1 reference

Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease

21 January 2018

1 reference

Serum interleukin 1 receptor antagonist as an independent marker of non-alcoholic steatohepatitis in humans.

21 January 2018

1 reference

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

21 January 2018

1 reference

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

21 January 2018

1 reference

Liver fat in the pathogenesis of insulin resistance and type 2 diabetes

21 January 2018

1 reference

Sterol intermediates from cholesterol biosynthetic pathway as liver X receptor ligands.

21 January 2018

1 reference

Desmosterol can replace cholesterol in sustaining cell proliferation and regulating the SREBP pathway in a sterol-Delta24-reductase-deficient cell line

21 January 2018

1 reference

Mutations in the 3beta-hydroxysterol Delta24-reductase gene cause desmosterolosis, an autosomal recessive disorder of cholesterol biosynthesis

21 January 2018

1 reference

Studies on the cholesterol-free mouse: strong activation of LXR-regulated hepatic genes when replacing cholesterol with desmosterol

21 January 2018

1 reference

Regulation of cellular response to oncogenic and oxidative stress by Seladin-1

21 January 2018

1 reference

3beta-Hydroxysteroid-delta24 reductase is a hydrogen peroxide scavenger, protecting cells from oxidative stress-induced apoptosis

21 January 2018

1 reference

Prosurvival effect of DHCR24/Seladin-1 in acute and chronic responses to oxidative stress

21 January 2018

1 reference

Lipid metabolite profiling identifies desmosterol metabolism as a new antiviral target for hepatitis C virus.

21 January 2018

1 reference

Hepatitis C Virus Impairs p53 via Persistent Overexpression of 3 -Hydroxysterol 24-Reductase

21 January 2018

1 reference

Dysmetabolic changes associated with HCV: a distinct syndrome?

21 January 2018

1 reference

The role of serum non-cholesterol sterols as surrogate markers of absolute cholesterol synthesis and absorption

21 January 2018

1 reference

Nonalcoholic fatty liver disease

21 January 2018

1 reference

7 January 2021

Cholesterol synthesis is increased and absorption decreased in non-alcoholic fatty liver disease independent of obesity

1 reference

7 January 2021

Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population

1 reference

7 January 2021

The validity of serum squalene and non-cholesterol sterols as surrogate markers of cholesterol synthesis and absorption in type 2 diabetes

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.26342

1 reference

release_yqiuc7bqo5efpbd3g26nspee3q

25 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yqiuc7bqo5efpbd3g26nspee3q

24 November 2022

mapped directly with Wikidata item

1 reference